U.S. Electrical Stock News

NYSE:ARES
NYSE:ARESCapital Markets

Ares Management (ARES) Could Be 12% Below Fair Value On Record Fundraising And Dividends

Ares Management (ARES) just reported a busy second quarter, combining record fundraising and higher revenue with fresh dividend declarations for both its common and preferred stock. Investors now have new numbers and payout details to weigh. See our latest analysis for Ares Management. Ares Management’s latest earnings and dividend news landed alongside a sharp 12.73% 1 month share price return and a 7.64% 3 month share price return, yet the stock is still down 22.99% on a year to date share...
NasdaqGS:VSEC
NasdaqGS:VSECAerospace & Defense

VSE (VSEC) Trades Below Fair Value, Is Its Premium P/E Still Too Rich?

How VSE Stock Has Been Trading Around Recent Levels VSE (VSEC) has recently traded around $194.39, with the stock up about 1% over the past day but down roughly 15% over the past month. Over the past 3 months, the share price is higher by about 14%. Over longer horizons, VSE shows a year to date gain of about 7% and a 1 year total return of roughly 33%. Looking further back, the 3 year total return is very large at about 3x, while the 5 year total return is also very large at about 3.3x...
NasdaqGS:RGLD
NasdaqGS:RGLDMetals and Mining

Royal Gold (RGLD) Following Its $30 Million Buyback Is It Still Undervalued

Royal Gold (RGLD) recently completed a share repurchase, buying back 147,205 shares for US$30 million under its May 2026 authorization. This move has drawn fresh attention to how the company is managing capital and shareholder returns. See our latest analysis for Royal Gold. Royal Gold’s share price has eased in the short term, with the 1 day share price return down 2.31% and the 90 day share price return down 13.98%. However, the 5 year total shareholder return of 81.18% points to a very...
NasdaqGS:KNSA
NasdaqGS:KNSABiotechs

Kiniksa Pharmaceuticals International (KNSA) After Raised 2026 Guidance And Strong Q2 Results Looks Fully Valued

Kiniksa Pharmaceuticals International (KNSA) drew fresh attention after it raised its 2026 net product revenue guidance to US$980 million to US$995 million, following second quarter results and a company pipeline update. See our latest analysis for Kiniksa Pharmaceuticals International. Kiniksa Pharmaceuticals International’s recent guidance hike and strong second quarter results have come after a powerful run, with a year to date share price return of 76.98% and a 1 year total shareholder...
NasdaqGM:MRAM
NasdaqGM:MRAMSemiconductor

Everspin Technologies (MRAM) Stock Looks Below Fair Value On A 159% Five Year Run

Everspin Technologies has delivered a 158.5% share price gain over the past five years, yet the valuation picture is not one sided. A Discounted Cash Flow (DCF) intrinsic value estimate points to a sizable gap relative to the current US$14.53 share price, while broader checks suggest something closer to a mixed verdict than a clear bargain. The 158.5% return over five years highlights that long term holders have already seen a strong payoff. Any further upside case therefore needs to be...
NYSE:FVRR
NYSE:FVRRProfessional Services

Fiverr (FVRR) Is Down 14.6% After Cutting 2026 Revenue Outlook Amid AI Demand Headwinds – Has The Bull Case Changed?

In late July 2026, Fiverr International reported that second-quarter revenue fell to US$97.78 million from US$108.65 million a year earlier, even as net income increased to US$4.47 million and diluted EPS rose to US$0.12. At the same time, the company cut its third-quarter and full-year 2026 revenue guidance, citing AI-related demand and traffic headwinds and weaker activity in categories most exposed to automation, even though profitability improved over the first half of the year. Next,...
NYSE:AU
NYSE:AUMetals and Mining

AngloGold Ashanti (AU) Could Be 34% Undervalued As Buyback And Earnings Lift Confidence

AngloGold Ashanti (NYSE:AU) has drawn fresh attention after reporting higher half year earnings and free cash flow, approving a US$2b share buyback, and maintaining its 2026 production guidance despite lower output. See our latest analysis for AngloGold Ashanti. Despite the strong half year update, AngloGold Ashanti's recent share price performance has softened, with the stock down 14.49% over 90 days and 7.34% year to date. This is even as the 1 year total shareholder return is 71.66% and...
NYSE:IOT
NYSE:IOTSoftware

Samsara (IOT) Draws Earnings Attention, Is The Stock Cheap Or Pricey?

Samsara (IOT) is back in focus after its stock closed the latest session at $35.80, falling 7.61% for the day, as traders position around the company’s upcoming earnings release. See our latest analysis for Samsara. Since that drop, Samsara’s share price has moved higher again, with a 7 day share price return of 12.56% and a 90 day share price return of 22.24%, while the 3 year total shareholder return sits at 44.12%. This points to firm but recently accelerating momentum as investors...
NYSE:HUBS
NYSE:HUBSSoftware

HubSpot (HUBS) Leans on Breeze AI Ahead of Earnings – A New Core Growth Engine?

HubSpot recently saw increased investor attention ahead of its second-quarter 2026 earnings report on August 5, amid expectations for continued revenue growth and broader platform usage. A central focus is the Breeze AI platform and AI-powered capabilities, which are expected to deepen customer engagement and support expanding subscription adoption. We’ll now examine how anticipation around Breeze AI–driven adoption and the upcoming earnings report could reshape HubSpot’s broader investment...
NYSE:DCO
NYSE:DCOAerospace & Defense

Argan Stock Leads 3 Border Security Names Tied To Europe Migration Pressure

Border security and surveillance stocks are back in focus as Europe wrestles with Spain’s migrant influx, disputed returns to Morocco and fresh calls for tougher controls inside the Schengen Area. These headlines are reshaping how investors think about companies with exposure to border management, screening technology and related services. Some businesses could see stronger demand for their solutions, while others may face policy risk or political scrutiny. This article looks at 3 stocks from...
NasdaqGS:CEG
NasdaqGS:CEGElectric Utilities

Constellation Energy (CEG) Draws Earnings Focus, Is A 26% Undervalued View Still Convincing?

Constellation Energy (CEG) is in focus as investors position ahead of its quarterly earnings report expected on August 6. The stock is reacting to mixed signals around earnings expectations and the possibility of another estimate beat. See our latest analysis for Constellation Energy. The recent pullback, with a 7 day share price return down 4.23% and a 90 day share price return down 14.64%, sits against a three year total shareholder return of 157.99%. Momentum has cooled in the short term,...
NasdaqGM:MNKD
NasdaqGM:MNKDBiotechs

Why MannKind (MNKD) Is Down 5.3% After Dual Lung And Heart Failure Milestones And What's Next

In late July 2026, MannKind reported positive topline Phase 1b results for its inhaled nintedanib in idiopathic pulmonary fibrosis and secured FDA approval for Furoscix ReadyFlow, an at-home furosemide autoinjector for adults with heart failure or chronic kidney disease. Together, these milestones highlight MannKind’s push to extend its Technosphere and drug-delivery expertise into chronic lung disease and out-of-hospital heart failure care, broadening its potential revenue sources beyond...
NasdaqGS:WIX
NasdaqGS:WIXIT

Wix.com (WIX) Faces AI Doubts On A 30% Undervalued View

Wix.com (NasdaqGS:WIX) is back in focus after a class action lawsuit was filed in the United States District Court for the Northern District of Illinois, challenging past disclosures about its AI offerings. See our latest analysis for Wix.com. Despite the legal questions around its AI disclosures and a series of analyst downgrades, Wix.com’s 7 day share price return of 7.04% and 30 day share price return of 12.58% sit against a much weaker picture. The year to date share price return is down...
NYSE:BEN
NYSE:BENCapital Markets

Record AUM, Net Inflows and Rebrand Might Change The Case For Investing In Franklin Resources (BEN)

In late July 2026, Franklin Resources, Inc. reported third‑quarter results showing revenue of US$2.36 billion and net income of US$171.5 million, alongside a US$33.0 million impairment of intangible assets and confirmation of an ongoing share repurchase program totaling US$7.17 billion since 2013. The company also recorded record US$1.80 trillion in assets under management with US$18.4 billion in long-term net inflows and announced a corporate name change to Franklin Templeton, Inc.,...
NasdaqGS:WAY
NasdaqGS:WAYHealthcare Services

Is Waystar Holding (WAY) Undervalued Following Strong Q2 Results And Higher Guidance?

Waystar Holding (WAY) is back in focus after second quarter 2026 results, a higher full year revenue outlook, and fresh commentary on AI driven solutions and cross sell activity following the Iodine acquisition. See our latest analysis for Waystar Holding. Despite strong Q2 results and higher guidance, Waystar Holding’s recent trading has been weak. The share price is US$21.11, with a year-to-date share price return down 32.71% and a 1-year total shareholder return down 40.69%. This points to...
NasdaqGS:KRYS
NasdaqGS:KRYSBiotechs

Does KB801’s Single-Patient Signal And S&P 400 Move Change The Bull Case For Krystal Biotech (KRYS)?

In July 2026, Krystal Biotech disclosed in a U.S. patent filing response that a single neurotrophic keratitis patient treated with its investigational gene therapy KB801 in a discontinued study experienced complete closure of a persistent corneal epithelial defect, while emphasizing no safety concerns and that no efficacy conclusions should be drawn from this isolated case. At the same time, Krystal Biotech was moved from the small-cap focused S&P 600 into the mid-cap S&P 400 and its health...
NYSE:UHS
NYSE:UHSHealthcare

Why Universal Health Services (UHS) Is Up 8.1% After Strong Q2 Results And Massive Buybacks

Universal Health Services recently reported past second-quarter 2026 results showing higher sales of US$4,638.01 million and net income of US$358.45 million, alongside continued top-line and earnings growth for the first half of the year. In parallel, the company has repurchased 47.15 million shares for US$6.62 billions under its long-running buyback program, signaling management’s confidence while also putting in place an incremental delayed draw term loan facility of up to US$700 million...
NYSE:WHD
NYSE:WHDEnergy Services

Why Cactus (WHD) Is Up 17.9% After Q2 Beat, Dividend Hike And New Board Appointment

Cactus, Inc. reported its second-quarter 2026 results, with revenue rising to US$449.53 million and net income reaching US$49.00 million, while also approving a higher quarterly dividend of US$0.15 per Class A share and expanding its board with Joseph Elkhoury. Despite strong quarterly profit growth, the six-month figures show revenue increasing to US$837.88 million but net income easing to US$81.90 million and earnings per share from continuing operations dropping to US$0.01, highlighting...
NYSE:IDT
NYSE:IDTTelecom

IDT (IDT) Could Be 12% Undervalued On Its AI And Subscription Growth Story

IDT stock reaction and recent performance IDT (IDT) has drawn fresh attention after recent trading, with the stock last closing at US$65.86. It has shown gains over the past week, month and past 3 months that outpaced its 1 year total return. See our latest analysis for IDT. For context, IDT’s recent 30.2% year to date share price return and 188.8% three year total shareholder return point to strong momentum over time. The recent 28.8% 90 day share price move suggests that trend has been...
NYSE:NFG
NYSE:NFGGas Utilities

Dollar General Stock And 2 Defensive Dividend Picks For More Stable Income

Regulators are tightening the rules, economic readings are shifting and businesses are adjusting how they operate. For income focused investors, that mix can put more value on companies that pay reliable dividends while keeping risk in check. This article looks at how the latest policy changes and economic signals connect to a curated Risk-Managed Dividend Stocks screener. It focuses on 3 stocks that appear positively exposed to the recent news, with solid dividend histories and relatively...
NasdaqGS:ECHO
NasdaqGS:ECHOMedia

Should Hughes Chapter 11 and SpaceX Spectrum Sale Reshape EchoStar’s (ECHO) Long‑Term Investment Narrative?

EchoStar recently disclosed that its subsidiary Hughes Network Systems plans to file for Chapter 11 bankruptcy protection, burdened by a US$1.50 billion debt obligation and a sharp subscriber drop from 1.56 million in 2020 to 681,000 in 2026 amid pressure from Low Earth Orbit satellite competitors such as Starlink. At the same time, EchoStar has been reshaping its portfolio by selling wireless spectrum licenses to major players including AT&T and SpaceX, highlighted by a very large US$17.00...
NasdaqGS:CG
NasdaqGS:CGCapital Markets

Carlyle Group (CG) Following Steadier Redemptions Looks Cheap Against Its Fair Value

Carlyle Group (CG) is back in focus after Carlyle Credit Solutions Inc., its non-traded business development company, reported investor redemption requests of about 3.6% of outstanding shares, below the fund’s cap and below the prior quarter. See our latest analysis for Carlyle Group. Set against this steadier picture at Carlyle Credit Solutions, Carlyle Group’s stock has seen a 1-month share price return of 8.72% even as the year to date share price return is down 24.38%. The 3-year total...
NYSE:DAC
NYSE:DACShipping

Danaos (DAC) Rallies As Contract Coverage Keeps Fair Value In Focus

Danaos (NYSE:DAC) has drawn investor attention after its stock closed at $141.63, with performance over the past month and past 3 months, as well as a wide gap between market value and some valuation estimates. See our latest analysis for Danaos. For context, Danaos has shown strong momentum recently, with a 30 day share price return of 14.98% and a year to date share price return of 48.69%, while the 1 year total shareholder return sits at 61.71% and the 5 year total shareholder return at...
NYSE:AI
NYSE:AISoftware

Can C3.ai (AI) Justify Its Valuation After Earnings Hopes Meet Revenue And Cash Burn Fears?

Recent commentary around C3.ai (AI) has focused on its upcoming earnings, with investors weighing the possibility of improved profitability against expectations for weaker revenue and concerns over falling billings and cash burn. See our latest analysis for C3.ai. C3.ai’s recent 7 day share price return of 12.64% contrasts with a weaker year to date share price return. The 1 year total shareholder return has also fallen sharply, suggesting recent momentum is building from a low base as...